A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
Open to underrepresented populationsRace/ethnicity-specific condition
Phase
PHASE1
Enrollment
Not reported
Age range
— to —
Sex
ALL
Summary
An open-label Phase 1b study of DISC-3405 in participants with sickle cell disease, conducted across multiple U.S. hematology centers. (Dates and site coordinates were not available in the source record consulted and are pending a full API sync.)
Conditions studied
Anemia, Sickle CellSickle Cell Disease
Sign-up window
Check back for sign-up dates
Sponsors
Disc MedicineLead
Study locations
University of Alabama at Birmingham
Birmingham, Alabama
Site contact being verified
Emory University
Atlanta, Georgia
Site contact being verified
Augusta University
Augusta, Georgia
Site contact being verified
Innovative Hematology - Indiana Hemophilia & Thrombosis Center
Indianapolis, Indiana
Site contact being verified
Mount Sinai Hospital
New York, New York
Site contact being verified
Duke University Medical Center
Durham, North Carolina
Site contact being verified
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
Site contact being verified